Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T75256 | ||||
Target Name | MART-1 melanoma antigen | ||||
Synonyms | Antigen LB39AA; Antigen SK29AA; MART1; Melanoma antigen recognized by Tcells 1; Protein MelanA; MLANA | ||||
Target Type | Clinical Trial | ||||
Gene Name | MLANA | ||||
Biochemical Class | Melanoma antigen recognized by T cells 1 | ||||
UniProt ID | MAR1_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Melanoma | ||||
Example drug | Melanoma vaccine | Phase 3 | [521514], [1572592] | ||
Tissue | Skin | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: 1.64 Z-score: 0.76 P-value: 3.29E-02 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.